AU6974796A - Treatment and prevention of hiv infection and aids with sarcoid-derived antigens - Google Patents

Treatment and prevention of hiv infection and aids with sarcoid-derived antigens

Info

Publication number
AU6974796A
AU6974796A AU69747/96A AU6974796A AU6974796A AU 6974796 A AU6974796 A AU 6974796A AU 69747/96 A AU69747/96 A AU 69747/96A AU 6974796 A AU6974796 A AU 6974796A AU 6974796 A AU6974796 A AU 6974796A
Authority
AU
Australia
Prior art keywords
sarcoid
aids
prevention
treatment
hiv infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69747/96A
Inventor
Jack L. Segal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JACK L SEGAL
Original Assignee
JACK L SEGAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JACK L SEGAL filed Critical JACK L SEGAL
Publication of AU6974796A publication Critical patent/AU6974796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
AU69747/96A 1995-09-21 1996-09-13 Treatment and prevention of hiv infection and aids with sarcoid-derived antigens Abandoned AU6974796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US412195P 1995-09-21 1995-09-21
US004121 1995-09-21
PCT/US1996/014614 WO1997010832A1 (en) 1995-09-21 1996-09-13 Treatment and prevention of hiv infection and aids with sarcoid-derived antigens

Publications (1)

Publication Number Publication Date
AU6974796A true AU6974796A (en) 1997-04-09

Family

ID=21709259

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69747/96A Abandoned AU6974796A (en) 1995-09-21 1996-09-13 Treatment and prevention of hiv infection and aids with sarcoid-derived antigens

Country Status (2)

Country Link
AU (1) AU6974796A (en)
WO (1) WO1997010832A1 (en)

Also Published As

Publication number Publication date
WO1997010832A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) The treatment of hiv and other viral infections using combinatory therapy
AU6816194A (en) Methods and materials for treatment of individuals infected with intracellular infectious agents
AU3879297A (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
AU5618494A (en) Identification and treatment of eye neovascular membranes
AU6391394A (en) Medical devices and methods of manufacture
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU1556497A (en) Agents for the treatment and prevention of aids
HUP9600455A3 (en) Use of quinoxalines combined with protease-inhibiting compounds for producing pharmaceutical compositions for treating aids and/or hiv infections
AU5758594A (en) Treatment of viral infections
AU658987B2 (en) Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection
HK1044896A1 (en) Method of treating hiv infection and related secondary infections thereof
EP0844850A4 (en) System for controlling the spread of hiv/aids and other infectious diseases
EP0789565A4 (en) Prevention of hiv infection
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU2473695A (en) Method of slowing the progression of hiv infection
AU3530395A (en) Treatment of viral infections
AU4812393A (en) Use of rapamycin in the treatment of aids
AU4767896A (en) Human immunodeficiency virus transcription inhibitors and methods of their use
AU6974796A (en) Treatment and prevention of hiv infection and aids with sarcoid-derived antigens
AU6829696A (en) Treatment of solutions
PL317876A1 (en) Combined treatment of hiv infections
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU4319393A (en) Use of indolocarbazols in aids treatment
AU5984196A (en) Treatment and prevention of prostatic disease